D-0471-2026 Class II Ongoing
Recall Details
- Product Type
- Drugs
- Report Date
- April 22, 2026
- Initiation Date
- March 6, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 91 vials
Product Description
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
OR
Code Information
Lot Number 01-27-2026@14S.5